Can you discuss the importance of the two principal PSCK9 CV outcome trials—ODYSSEY Outcomes and FOURIER—and how they are similar and in what ways they are different? What are the implications for the patient with T2D and ASCVD?

Can you discuss the importance of the two principal PSCK9 CV outcome trials—ODYSSEY Outcomes and FOURIER—and how they are similar and in what ways they are different? What are the implications for the patient with T2D and ASCVD?

Can you discuss the importance of the two principal PSCK9 CV outcome trials—ODYSSEY Outcomes and FOURIER—and how they are similar and in what ways they are different? What are the implications for the patient with T2D and ASCVD?


Created by

 CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Interventional Cardiologist's Perspective

Presenter

Deepak Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

Deepak Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

Executive Director of Interventional Cardiovascular ProgramsBrigham and Women’s HospitalHeart and Vascular CenterProfessor of Medicine, Harvard Medical SchoolBoston, USA